Antioxidant Effects of Salidroside in the Cardiovascular System
Open Access
- 1 January 2020
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1)
Abstract
Cardiovascular disease is one of the main human health risks, and the incidence is increasing. Salidroside is an important bioactive component of Rhodiola rosea L., which is used to treat Alzheimer’s disease, tumor, depression, and other diseases. Recent studies have shown that salidroside has therapeutic effects, to some degree, in cardiovascular diseases via an antioxidative mechanism. However, evidence‐based clinical data supporting the effectiveness of salidroside in the treatment of cardiovascular diseases are limited. In this review, we discuss the effects of salidroside on cardiovascular risk factors and cardiovascular diseases and highlight potential antioxidant therapeutic strategies.Keywords
Funding Information
- National Natural Science Foundation of China (81503421, 81673722)
- China Association for Science and Technology (2017QNRC001)
This publication has 88 references indexed in Scilit:
- Medical management of critical limb ischaemia: where do we stand today?Journal of Internal Medicine, 2013
- Salidroside Improves Homocysteine-Induced Endothelial Dysfunction by Reducing Oxidative StressEvidence-Based Complementary and Alternative Medicine, 2013
- Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient MiceEvidence-Based Complementary and Alternative Medicine, 2012
- Protective Effects of Salidroside on Epirubicin-Induced Early Left Ventricular Regional Systolic Dysfunction in Patients with Breast CancerDrugs in R&D, 2012
- Oxidative stress in health and disease: The therapeutic potential of Nrf2 activationMolecular Aspects of Medicine, 2011
- Lipid-induced insulin resistance: unravelling the mechanismThe Lancet, 2010
- Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteinsEuropean Journal of Pharmacology, 2009
- Effects of Radix et Rhizoma Rhodiolae Kirilowii on expressions of von Willebrand factor, hypoxia-inducible factor 1 and vascular endothelial growth factor in myocardium of rats with acute myocardial infarctionJournal of Chinese Integrative Medicine, 2009
- Salidroside protects cardiomyocyte against hypoxia-induced death: A HIF-1α-activated and VEGF-mediated pathwayEuropean Journal of Pharmacology, 2009
- Link between obesity and type 2 diabetesBest Practice & Research Clinical Endocrinology & Metabolism, 2005